Category
Every year, thousands of people research peptides, learn about the potential of compounds like BPC-157, CJC-1295, or NAD+ — and then stop cold at the same obstacle: the needle.
The syringe. The vial. The reconstitution kit. The sterile alcohol swabs. The need for refrigeration. The twice-daily injections that require military precision and a tolerance for self-administered shots. For most people, that’s not a wellness routine, it’s a clinical trial.
And then there’s the other route: oral capsules and powders that claim peptide benefits but deliver a fraction of them, most of the compound destroyed before it ever reaches your bloodstream.
The result? Millions of people who are genuinely interested in the cutting edge of peptide research are stuck between two imperfect options; or they walk away entirely.
Sublingual strips are changing that equation. By dissolving directly under the tongue and absorbing through mucosal tissue straight into the bloodstream, they sidestep both problems: no injections, no first-pass metabolism. It’s the same science, in a format that actually fits into a human life.
Here’s what the research says and why the delivery format you choose matters just as much as the compound itself.
Delivery format isn’t a minor detail. For peptides, short chains of amino acids that are notoriously fragile, it may be the most important variable of all.
Subcutaneous injection has long been the gold standard for peptide delivery. The logic is sound: inject directly under the skin, bypass the digestive system entirely, and achieve relatively predictable absorption into the bloodstream. For research-grade compounds, this method offers a high degree of bioavailability.
But the practical barriers are significant. Self-injection requires:
For researchers and high-level athletes with clinical support, these barriers are manageable. For the average person curious about peptide science? It’s a wall.
On the other end of the spectrum, oral peptide supplements face an entirely different problem: the digestive system destroys them.
Peptides are protein-based molecules. When you swallow them, your stomach acid and digestive enzymes — proteases like pepsin and trypsin — begin breaking them into individual amino acids before they can be absorbed. Even if some intact peptide molecules survive digestion, they then face the first-pass effect: a process where the liver metabolizes compounds absorbed from the gut before they ever reach systemic circulation.
The result is dramatically reduced bioavailability. Studies on orally administered peptides have shown absorption rates as low as 1-2% for some compounds. You’re paying for a research-grade molecule and absorbing a fraction of it.
This isn’t a manufacturing problem — it’s a fundamental biology problem. The oral route was never designed for peptide delivery. Which is exactly why the sublingual route is so significant.
Sublingual delivery isn’t a new concept. Physicians have used it for decades with compounds like nitroglycerin (for angina), certain hormones, and specific medications where rapid absorption is critical. The science is well-established. What’s changed is applying it to peptide compounds at research grade — and doing it in a convenient strip format.
The area under your tongue — the sublingual mucosa — is one of the most vascularly rich regions in the body. It’s lined with thin, permeable epithelium and sits directly over a dense network of capillaries and veins, including the sublingual vein and the deep lingual vein, which drain directly into the systemic circulation.
This means that compounds absorbed sublingually:
Research on sublingual drug delivery has consistently demonstrated superior bioavailability compared to oral administration for a range of compounds. A landmark comparison published in pharmacological literature found that sublingual administration could achieve bioavailability 3-10x higher than equivalent oral doses for certain molecular classes — particularly small to medium-sized peptide fragments.
The sublingual mucosa also has a slightly higher pH than the stomach, which is more favorable for peptide stability. Less acidity means less molecular degradation at the point of contact.
Peptides are particularly well-suited to sublingual delivery for two reasons. First, their molecular weight — many research peptides fall in the range that allows reasonable mucosal permeation. Second, the lack of proteolytic enzymes (the protein-digesting enzymes found in the gut) in the sublingual environment means the intact peptide molecule has a much better chance of reaching circulation unchanged.
Research suggests that the sublingual route may offer a viable middle ground between the high bioavailability of injection and the convenience of oral administration — particularly when formulation is optimized for mucosal absorption.
Sublingual delivery has existed as a pharmaceutical concept for decades — but it was primarily executed through liquid drops, sprays, or traditional tablets placed under the tongue. Each format had limitations: liquids are messy and imprecise, tablets don’t always dissolve evenly, and sprays can miss the optimal delivery zone.
Thin-film strip technology represents a meaningful evolution in sublingual delivery.
Sublingual strips are thin, flexible films — similar in appearance to breath-freshening strips — designed to dissolve completely within seconds of contact with the moist sublingual mucosa. The active compounds are embedded within a polymer matrix (typically hydroxypropyl methylcellulose or pullulan-based films) that dissolves rapidly on contact with saliva, releasing the compounds directly at the absorption site.
The engineering advantages are significant:
Here’s a truth that often gets lost in conversations about bioavailability percentages and research protocols: a compound you don’t use has 0% bioavailability.
The best delivery method is the one you’ll actually stick with. Research on medication adherence consistently shows that complexity, pain, and inconvenience are the primary drivers of non-compliance. A sublingual strip that takes 10 seconds and requires no equipment is, practically speaking, orders of magnitude easier to maintain than a twice-daily injection protocol.
When convenience meets science-backed delivery, you get something the injectable format rarely achieves: consistent daily use over the long term. And for compounds studied for their cumulative effects, that consistency is everything.
FitDaily has built its entire product line around one premise: research-grade compounds shouldn’t require a clinical setting. Each strip is formulated with pharmaceutical-grade peptides and designed for optimal sublingual delivery. Here’s what’s in the lineup.
Wolverine strips are formulated with research-grade BPC-157 and TB-500 — two of the most extensively studied peptides in the recovery and repair literature. BPC-157 (Body Protection Compound-157) is a synthetic peptide derived from a protein found in gastric juice, studied extensively for its effects on tissue repair signaling pathways. TB-500 (Thymosin Beta-4) is a naturally occurring peptide studied for its role in cellular migration and repair processes.
Together, they represent one of the most researched peptide combinations in the sports science and longevity literature. Research suggests BPC-157 may play a role in angiogenesis (new blood vessel formation) and extracellular matrix remodeling. TB-500 has been studied for its potential involvement in actin polymerization and wound healing at the cellular level.
Wolverine is formulated to support the kind of rigorous research protocols that serious athletes and biohackers run. Learn more about Wolverine →
CJC-1295/Ipamorelin strips combine two of the most studied growth hormone-releasing peptides in a single delivery format. CJC-1295 is a GHRH (growth hormone-releasing hormone) analogue studied for its ability to stimulate sustained GH release. Ipamorelin is a selective GHRP (growth hormone-releasing peptide) that research suggests produces a clean GH pulse with minimal cortisol or prolactin stimulation compared to older GHRPs.
The combination is studied for its potential effects on body composition, recovery, and sleep quality — and has been a staple of longevity-focused research protocols for years. The challenge has always been delivery: both compounds have traditionally required injection. FitDaily’s sublingual format offers a needle-free alternative formulated with research-grade compounds. Learn more about CJC-1295/Ipamorelin →
Glow strips are formulated with GHK-Cu (copper peptide), BPC-157, and TB-500 — a combination focused on the intersection of skin science and tissue repair research. GHK-Cu is one of the most extensively studied copper-binding peptides in dermatological research, with literature exploring its role in collagen synthesis stimulation, antioxidant activity, and skin remodeling processes.
Research on GHK-Cu spans decades and includes studies on wound healing, anti-inflammatory effects at the cellular level, and potential upregulation of repair genes. Combined with BPC-157 and TB-500, the Glow formulation represents a research-grade stack for those studying skin health and recovery from the inside out. Learn more about Glow →
NAD+ strips deliver nicotinamide adenine dinucleotide — one of the most researched molecules in longevity science — via sublingual absorption. NAD+ is a coenzyme found in every cell of the body, critical to mitochondrial function, DNA repair pathways, and the activity of sirtuins (proteins studied extensively in aging research).
NAD+ levels decline significantly with age, and this decline has been linked in research to reduced cellular energy production and impaired repair processes. Oral NAD+ supplementation faces absorption challenges; IV infusions exist but are expensive and require clinical settings. Sublingual delivery represents a compelling middle ground — research suggests improved bioavailability over oral routes, in a format that’s practical for daily use. Learn more about NAD+ strips →
All FitDaily products are formulated for research purposes and intended for investigational use. Descriptions reference published scientific literature and do not constitute medical claims.
Sublingual peptide strips aren’t a niche product for a niche audience. The barrier-removal they represent opens up research-grade compounds to a much broader population than injectable formats ever could.
Competitive athletes, weekend warriors, and physical performers have driven much of the interest in peptide research — particularly compounds studied for recovery, repair, and tissue remodeling. The problem has always been the injection barrier: few team environments, travel schedules, or daily routines accommodate a twice-daily injection protocol. Sublingual strips dissolve that barrier. No sterile prep, no cold storage requirements, no airport security complications.
The quantified self community has long been at the frontier of peptide research. These are the people who track biomarkers, run n=1 experiments, and read primary research literature. They understand the science — and many have been frustrated by the injection requirements that gate access to the compounds they’re most interested in. Sublingual strips offer a format that matches the sophistication of the research without the clinical overhead.
Perhaps the largest segment is people who’ve heard about peptide research — from longevity podcasts, health journalists, or their physician — and are interested in exploring it personally, but aren’t willing to self-inject. This population has effectively been locked out of meaningful peptide research. Sublingual strips change the access equation entirely.
If you’ve ever been interested in what the research says about BPC-157, CJC-1295, NAD+, or GHK-Cu — but the needle requirement stopped you — there’s now a research-grade option that fits into a normal morning routine.
Sublingual delivery and injection each have distinct bioavailability profiles that vary by compound. Injectable peptides achieve high systemic absorption but require reconstitution and sterile technique. Research on sublingual delivery demonstrates significantly higher bioavailability compared to oral ingestion for many peptide classes, by bypassing first-pass hepatic metabolism and digestive degradation. The practical advantage of sublingual strips — consistent daily compliance — may offset bioavailability differences in many research contexts. For research purposes, both formats are used, and the optimal choice depends on the specific compound and protocol.
The strip itself dissolves within 10–30 seconds of placement under the tongue. The mucosal absorption process begins immediately upon contact with the tissue. Research on sublingual drug delivery generally shows that absorption begins within minutes, with peak blood concentration timing varying by compound. The sublingual route is notably faster than oral ingestion due to direct vascular access — it’s one of the reasons sublingual nitroglycerin is used for acute angina rather than swallowed tablets.
FitDaily currently offers sublingual strips formulated with BPC-157, TB-500, CJC-1295, Ipamorelin, GHK-Cu, and NAD+. These represent some of the most-researched compounds in the peptide science literature. The formulation of each strip is designed to optimize sublingual delivery for the specific molecular characteristics of each compound.
Unlike injectable peptides, which typically require refrigeration (especially once reconstituted), FitDaily’s sublingual strips are formulated for room temperature stability. They can be stored in typical ambient conditions without cold chain requirements. This makes them significantly more practical for travel, daily carry, and long-term storage than injectable alternatives.
The distinction comes down to formulation quality and delivery engineering. FitDaily uses research-grade compounds — the same quality standards applied in published peptide research — rather than the food-grade or supplement-grade alternatives used in some products. The strip film itself is engineered for rapid dissolution and optimal sublingual contact, not simply a traditional oral supplement pressed into strip form. The focus is on getting the right compound to the right absorption site in the right format.
In the United States, peptides like BPC-157, TB-500, CJC-1295, Ipamorelin, GHK-Cu, and NAD+ are legal to purchase for research purposes. They are not FDA-approved for human therapeutic use, and FitDaily’s products are sold and intended for research purposes only. The regulatory landscape for peptides varies by country, so purchasers outside the US should verify local regulations. FitDaily’s products are not intended to diagnose, treat, cure, or prevent any disease or condition.
The science of peptide research has advanced dramatically over the past two decades. What hasn’t kept pace is delivery technology — until now.
Injections remain a viable research tool for those with clinical support and a tolerance for daily needles. But they’ve always represented a ceiling on who can meaningfully participate in peptide research. Oral supplements, despite their convenience, have been limited by the fundamental biology of digestive degradation.
Sublingual strips occupy a different position in this landscape: research-grade compounds, delivered via a format that’s backed by decades of pharmaceutical science, in a form that anyone can use consistently without clinical infrastructure.
If you’ve been following the peptide research literature and waiting for a format that makes sense for your life — this is it.
Explore FitDaily’s full lineup of sublingual peptide strips at fitdaily.com/shop — research-grade formulations, no needles required.
Stay current with the latest in peptide science and sublingual delivery research by following FitDaily on Instagram (@wearefitdaily), YouTube (@wearefitdaily), and TikTok (@wearefitdaily).
Research-grade peptide strips. No needles. Made in the USA.
FEATURED PRODUCT
Research-grade BPC-157. Fast-acting sublingual delivery. No needles.
Explore FitDaily’s lineup of research-grade sublingual strips.
🔬
Science-backed guides on peptide research and sublingual delivery.
